Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | completed | Phase 3 | 3,010 | UNICANCEROTHER | 1 | Jul 19, 2013 | clinicaltrials |
| NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | completed | Phase 3 | 280 | Gruppo Italiano Mammella (GIM)OTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00103233 | Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer | completed | Phase 3 | — | SWOG Cancer Research NetworkNETWORK | 0 | Jun 24, 2013 | clinicaltrials |
| NCT00711529 | Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes. | completed | Phase 3 | 27 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00002967 | Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer | completed | Phase 3 | — | NSABP Foundation IncNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | completed | Phase 3 | 1,512 | UNICANCEROTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00671918 | Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma | completed | Phase 3 | 186 | Navidea BiopharmaceuticalsINDUSTRY | 2 | Jun 17, 2013 | clinicaltrials |
| NCT01106040 | Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes | completed | Phase 3 | 163 | Navidea BiopharmaceuticalsINDUSTRY | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00003440 | Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic | completed | Phase 3 | 580 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | completed | Phase 3 | 446 | Ludwig-Maximilians - University of MunichOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00005079 | Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01433562 | Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients | completed | Phase 2 / Phase 3 | 40 | Dexa Medica GroupINDUSTRY | 1 | May 13, 2013 | clinicaltrials |
| NCT00083304 | Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer(ENRICH) | completed | Phase 3 | 368 | Spectrum Pharmaceuticals, IncINDUSTRY | 15 | May 10, 2013 | clinicaltrials |
| NCT00002528 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer(10-93) | completed | Phase 3 | 473 | ETOP IBCSG Partners FoundationNETWORK | 9 | Apr 4, 2013 | clinicaltrials |
| NCT00002529 | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer(12-93) | completed | Phase 3 | 452 | ETOP IBCSG Partners FoundationNETWORK | 7 | Apr 4, 2013 | clinicaltrials |
| NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer(15-95) | completed | Phase 3 | 344 | ETOP IBCSG Partners FoundationNETWORK | 2 | Apr 4, 2013 | clinicaltrials |
| NCT00003638 | Vaccine Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 3 | 950 | Oncothyreon Canada Inc.INDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00122356 | Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment(BATMAN) | completed | Phase 3 | 303 | Barwon HealthOTHER_GOV | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00008203 | Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | completed | Phase 3 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00291759 | ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation. | completed | Phase 3 | 3,858 | AstraZenecaINDUSTRY | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00016406 | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer | completed | Phase 3 | 399 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | completed | Phase 3 | 1,558 | SWOG Cancer Research NetworkNETWORK | 0 | Jan 24, 2013 | clinicaltrials |
| NCT01611051 | A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy | completed | Phase 3 | 330 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00262899 | Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions | completed | Phase 3 | 331 | Georgetown UniversityOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00089479 | A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | completed | Phase 3 | 2,611 | Hoffmann-La RocheINDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00230711 | Physical Activity Promotion in Cancer Follow-Up Care | completed | Phase 3 | 300 | The Miriam HospitalOTHER | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00002920 | S9630, Medroxyprogesterone in Treating Women With Breast Cancer | completed | Phase 3 | 313 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00201890 | Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" | completed | Phase 3 | 103 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT00917748 | Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) | completed | Phase 3 | 84 | SanofiINDUSTRY | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00605267 | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | completed | Phase 3 | 197 | AstraZenecaINDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00256698 | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy(FACT) | completed | Phase 3 | 514 | AstraZenecaINDUSTRY | 12 | Aug 1, 2012 | clinicaltrials |
| NCT00008411 | Docetaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 3 | 90 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00343616 | Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | completed | Phase 3 | 135 | ETOP IBCSG Partners FoundationNETWORK | 6 | Jul 27, 2012 | clinicaltrials |
| NCT00369850 | Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | completed | Phase 3 | 458 | ETOP IBCSG Partners FoundationNETWORK | 8 | Jul 27, 2012 | clinicaltrials |
| NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | completed | Phase 3 | 74 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 342 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 2, 2012 | clinicaltrials |
| NCT00006459 | Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00849030 | ATAC - Arimidex, Tamoxifen Alone or in Combination | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT01587248 | Use of Harmonic in Breast Surgery(HMRM) | completed | Phase 3 | 152 | Aga Khan UniversityOTHER | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00670878 | Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer | completed | Phase 3 | 799 | Ludwig-Maximilians - University of MunichOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
| NCT01508546 | Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer | completed | Phase 3 | 565 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00002646 | Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | completed | Phase 3 | 1,500 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jan 5, 2012 | clinicaltrials |
| NCT00245050 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | completed | Phase 3 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00309556 | Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer | completed | Phase 3 | 536 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jul 19, 2013source: clinicaltrials